Estrogen receptor alpha and NFATc1 bind to a bone mineral density-associated SNP to repress WNT5B in osteoblasts
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 109 (1) , 97-115
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AR-064354)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
This publication has 93 references indexed in Scilit:
- Estrogen synthesis and signaling pathways during aging: from periphery to brainTrends in Molecular Medicine, 2013
- WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancerEMBO Molecular Medicine, 2013
- Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumorsOncogene, 2012
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fractureNature Genetics, 2012
- A unique chromatin signature uncovers early developmental enhancers in humansNature, 2010
- Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cellsJournal of Bone and Mineral Research, 2010
- NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiationBone, 2009
- Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survivalThe EMBO Journal, 2008
- Genome-wide analysis of estrogen receptor binding sitesNature Genetics, 2006
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003